Home
About
FAQ
History (1)
Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Lymphoma, Non-Hodgkin
One or more keywords matched the following properties of
Lymphoma, Non-Hodgkin
Property
Value
label
Lymphoma, Non-Hodgkin
Search Criteria
Non Hodgkin Lymphoma